GlaxoSmithKline PLC (GSK): Price and Financial Metrics

GlaxoSmithKline PLC (GSK): $38.39

-0.95 (-2.41%)

POWR Rating

Component Grades














  • GSK scores best on the Growth dimension, with a Growth rank ahead of 98.42% of US stocks.
  • The strongest trend for GSK is in Stability, which has been heading up over the past 48 weeks.
  • GSK ranks lowest in Momentum; there it ranks in the 13th percentile.

GSK Stock Summary

  • GSK has a market capitalization of $105,926,679,766 -- more than approximately 97.55% of US stocks.
  • GSK's went public 35.24 years ago, making it older than 92.2% of listed US stocks we're tracking.
  • In terms of volatility of its share price, GSK is more volatile than only 7.59% of stocks we're observing.
  • Stocks that are quantitatively similar to GSK, based on their financial statements, market capitalization, and price volatility, are DE, MMM, GE, CAT, and IBM.
  • GSK's SEC filings can be seen here. And to visit Glaxosmithkline Plc's official web site, go to

GSK Stock Price Chart Interactive Chart >

Price chart for GSK

GSK Price/Volume Stats

Current price $38.39 52-week high $42.68
Prev. close $39.34 52-week low $33.26
Day low $38.37 Volume 4,363,100
Day high $38.70 Avg. volume 4,824,671
50-day MA $40.33 Dividend yield 5.44%
200-day MA $38.23 Market Cap 103.37B

GlaxoSmithKline PLC (GSK) Company Bio

GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company’s wellness products include Panadol and Panadol Cold & Flu, ENO and Tums - antacids, and Nicorette (US), Nicoderm, NiQuitin CQ, and Nicabate - treatment of nicotine withdrawal, Sensodyne - to ttreat and prevent dental sensitivity, Polident, Poligrip, and Corega to enhance comfort of fitted denture, and Aquafresh for the prevention of gum disease and bad breath. The company was founded in 1935 and is based, the United Kingdom.

GSK Latest News Stream

Event/Time News Detail
Loading, please wait...

GSK Latest Social Stream

Loading social stream, please wait...

View Full GSK Social Stream

Latest GSK News From Around the Web

Below are the latest news stories about Glaxosmithkline Plc that investors may wish to consider to help them evaluate GSK as an investment opportunity.

‘I don’t think we’ve done enough to get vaccines overseas’: Doctor

Dr. Arthur Caplan, NYU Langone Health, Division of Medical Ethics at NYU School of Medicine, joins Yahoo Finance to discuss the latest on the coronavirus vaccines and booster shots.

Yahoo | September 24, 2021

Why Vir Biotechnology Stock Is Sinking This Week

Shares of Vir Biotechnology (NASDAQ: VIR) were sinking 18.1% for the week as of the market close on Thursday. Vir was pulled down by the overall stock market sell-off earlier this week. It's best to avoid making investment decisions based on analysts' downgrades (and upgrades, for that matter).

Yahoo | September 24, 2021

Healthcare is still ‘stuck in a world of white coats’: 23andMe CEO

23andMe CEO Anne Wojcicki joins 'Influencers with Andy Serwer' to discuss the politicization of medicine amid the COVID-19 pandemic.

Yahoo | September 24, 2021

STAT+: Pharmalittle: Pfizer CEO rallies employees to fight drug-price negotiations; Glaxo head pressured by another activist fund

GlaxoSmithKline CEO Emma Walmsley has come under pressure from a second activist hedge fund, which has taken a stake worth about $14 million to push for change at the top.

STAT News | September 23, 2021

Cerebral Palsy Treatment Market Size, Top Countries Data, Industry Share, Company Overview, Regional Economy, Development and Top Key Players are GlaxoSmithKline, Pfizer, Abbott Laboratories, GW Pharmaceuticals ETC.

Cerebral Palsy (CP) is an umbrella term for a group of disorders that impede an individuals movement ability and physical balance & posture. CP is one of the most common motor disabilities that occur in childhood. Abnormal brain development, mostly []

iCrowdNewswire | September 23, 2021

Read More 'GSK' Stories Here

GSK Price Returns

1-mo -5.95%
3-mo -2.70%
6-mo 10.38%
1-year 7.47%
3-year 11.32%
5-year 13.76%
YTD 8.95%
2020 -17.79%
2019 29.12%
2018 13.70%
2017 -3.03%
2016 -1.10%

GSK Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full GSK Dividend History

Continue Researching GSK

Here are a few links from around the web to help you further your research on Glaxosmithkline Plc's stock as an investment opportunity:

Glaxosmithkline Plc (GSK) Stock Price | Nasdaq
Glaxosmithkline Plc (GSK) Stock Quote, History and News - Yahoo Finance
Glaxosmithkline Plc (GSK) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9017 seconds.